182 related articles for article (PubMed ID: 8926686)
21. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
[TBL] [Abstract][Full Text] [Related]
22. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma.
Caron H
Med Pediatr Oncol; 1995 Apr; 24(4):215-21. PubMed ID: 7700165
[TBL] [Abstract][Full Text] [Related]
23. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
24. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.
Matthay KK; Sather HN; Seeger RC; Haase GM; Hammond GD
J Clin Oncol; 1989 Feb; 7(2):236-44. PubMed ID: 2915240
[TBL] [Abstract][Full Text] [Related]
25. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
26. [Long-term survival following neuroblastoma stage IV--a case report].
Eschenbach C; Gutjahr P
Klin Padiatr; 1985; 197(3):245-8. PubMed ID: 4010221
[TBL] [Abstract][Full Text] [Related]
27. Age and prognosis in neuroblastoma. Review of 112 patients younger than 2 years.
Jereb B; Bretsky SS; Vogel R; Helson L
Am J Pediatr Hematol Oncol; 1984; 6(3):233-43. PubMed ID: 6517224
[TBL] [Abstract][Full Text] [Related]
28. Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children.
Hann HW; Evans AE; Cohen IJ; Leitmeyer JE
N Engl J Med; 1981 Aug; 305(8):425-9. PubMed ID: 7254280
[TBL] [Abstract][Full Text] [Related]
29. Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator.
Nakagawara A; Ikeda K; Tsuda T; Higashi K; Okabe T
J Pediatr Surg; 1987 May; 22(5):415-8. PubMed ID: 3585663
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of modern therapy for neuroblastoma].
Yokoyama J; Hara S; Kuroda T; Hoshino K; Tamura T; Hosoya R; Nishimura K
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1167-70. PubMed ID: 1944179
[TBL] [Abstract][Full Text] [Related]
31. The treatment of advanced neuroblastoma. Results of the Spanish Neuroblastoma Study Group (SNSG) studies.
Castel V; García-Miguel P; Melero C; Navajas A; Navarro S; Molina J; Badal MD; Ruiz-Jimenez JI
Eur J Cancer; 1995; 31A(4):642-5. PubMed ID: 7576986
[TBL] [Abstract][Full Text] [Related]
32. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
[TBL] [Abstract][Full Text] [Related]
33. Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study.
Castleberry RP; Shuster JJ; Altshuler G; Smith EI; Nitschke R; Winick N; McWilliams N; Joshi V; Hayes FA
J Clin Oncol; 1992 Aug; 10(8):1299-304. PubMed ID: 1634920
[TBL] [Abstract][Full Text] [Related]
34. [A preliminary treatment report of the Study Group of Japan for Advanced Neuroblastoma].
Sawaguchi S; Kaneko M; Nakajo T; Sawada T; Takahashi H; Tsuchida Y
Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):1020-6. PubMed ID: 2674308
[TBL] [Abstract][Full Text] [Related]
35. Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan.
Sawaguchi S; Kaneko M; Uchino J; Takeda T; Iwafuchi M; Matsuyama S; Takahashi H; Nakajo T; Hoshi Y; Okabe I
Cancer; 1990 Nov; 66(9):1879-87. PubMed ID: 2224784
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factor in neuroblastoma.
Evans AE; D'Angio GJ; Propert K; Anderson J; Hann HW
Cancer; 1987 Jun; 59(11):1853-9. PubMed ID: 3567848
[TBL] [Abstract][Full Text] [Related]
37. [The significance of the surgical treatment of neuroblastoma].
Grüssner R; nii-Amon Kotei D; Gutjahr P; Hofmann-von Kap-herr S
Z Kinderchir; 1982 Oct; 37(2):56-61. PubMed ID: 7158076
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of oncogene activation in human neuroblastomas.
Brodeur GM; Seeger RC; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
Cancer; 1986 Jul; 58(2 Suppl):541-5. PubMed ID: 3719548
[TBL] [Abstract][Full Text] [Related]
39. Stage IV neuroblastoma in infants. Long-term survival.
Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE
Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536
[TBL] [Abstract][Full Text] [Related]
40. Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu area.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ogami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S
J Pediatr Surg; 1995 May; 30(5):715-21. PubMed ID: 7623237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
